Anatomy of an antibody, and related misadventures in developing an effective treatment for septic shock
Gibaldi, M.
PharmacoTherapy 13(4): 302-308
1993
ISSN/ISBN: 0277-0008 PMID: 8361858 Document Number: 405792
Document emailed within 1 workday
Related Documents
Friedman, G.; Jankowski, S.; Shahla, M.; Goldman, M.; Rose, R.M.; Kahn, R.J.; Vincent, J.L. 1996: Administration of an antibody to E-selectin in patients with septic shock Critical Care Medicine 24(2): 229-233Wacharasint, P.; Lertamornpong, A.; Wattanathum, A.; Wongsa, A. 2012: Predicting fluid responsiveness in septic shock patients by using 3 dynamic indices: is it all equally effective? Journal of the Medical Association of Thailand 95(Suppl 5): S149-S156
Lillehei, R.C.; Dietzman, R.H.; Motsay, G.J.; Schultz, L.S.; Romero, L.H.; Beckman, C.B. 1972: The pharmacologic approach to the treatment of shock. I. Defining traumatic, septic, and cardiogenic shock Geriatrics 27(7): 73-83
Tahara, H.; Katoh, Y.; Yano, H.; Kanbara, N.; Kohri, K.; Kurita, T. 1993: Septic shock induced by extracorporeal shock wave lithotripsy treatment with percutaneous nephrostomy in 5 cases with urolithiasis Hinyokika Kiyo. Acta Urologica Japonica 39(12): 1119-1124
Dolinescu, C. 1988: Clinical and therapeutic aspects in surgery-related septic shock Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi Suppl: 42-45
Gendzwiłł, A. 2007: Reactive oxygen species and vascular hyporeactivity in septic shock. Part II--scavengers and vascular hyporeactivity in septic shock Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 23(136): 284-287
Sheagren, J.N. 1991: Corticosteroids for the treatment of septic shock Infectious Disease Clinics of North America 5(4): 875-882
Richard, C. 1993: Symptomatic treatment of septic shock La Revue du Praticien 43(1): 46-53
Ellenbogen, C. 1982: Treatment priorities for septic shock American Family Physician 25(2): 163-167
Jacob, E.; Gassner, S.; Shapira, Z. 1972: Phentolamine in the treatment of septic shock Harefuah 83(5): 189-194
Martin, C.; Saux, P.; Aknin, P.; Albanese, J.; Bonneru, J.J.; Gouin, F. 1988: Value of noradrenaline in the treatment of hyperkinetic septic shock Presse Medicale 17(15): 754
Robin, M.; Le Gall, J.R. 1975: Septic shock. Symptoms, etiology and treatment La Revue du Praticien 25(11): 841-848
Kneyber, M.C.J.; van Heerde, M.; Henneveld, H.T. 2010: Primary management and treatment of paediatric septic shock Nederlands Tijdschrift Voor Geneeskunde 154: A1195
Jastrzebski, J.; Kawecka, M. 1982: Respiratory insufficiency and its treatment in patients with septic shock Polski Tygodnik Lekarski 37(17): 469-472
Eckert, P.; Eichen, R.; Schassan, H.H. 1976: Treatment of peritonitis within the scope septic shock with antibiotics Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 47(6): 318-321
Berk, J.L.; Hagen, J.F.; Dunn, J.M. 1970: The role of beta adrenergic blockade in the treatment of septic shock Surgery Gynecology and Obstetrics 130(6): 1025-1034
Cohen, J.; Exley, A.R. 1993: Treatment of septic shock with antibodies to tumour necrosis factor Schweizerische Medizinische Wochenschrift 123(11): 492-496
Goto, Y. 1979: Microcirculatory changes during endotoxin shock: application of Shwartzman reaction as a septic shock model Masui. Japanese Journal of Anesthesiology 28(9): 914-921
Mojzes, L.; Dosa, E.; Foldes, V.; Kiss, L. 1989: The differential diagnosis of the septic shock and toxic shock syndromes Acta Medicinae Legalis et Socialis 39(1): 251-257
Bojić, I. 1996: Active mediators in the pathogenesis of septic shock and the importance of their neutralization in the treatment of patients Vojnosanitetski Pregled 53(6): 511-518